Table 6.
Lactate dehydrogenase level and liver and kidney function tests of the participants (N = 150).
| Parameters | Groups | ||||
|---|---|---|---|---|---|
| Control group | Type 1 diabetic patients | Type 1 diabetic patients with COVID-19 | Test value | p value | |
| LDH (U/l) | 157.5 ± 9.6 | 188.5 ± 30.34a | 229 ± 45.15ab | 61.935 | <0.001 |
| ALT (U/l) | 13.33 ± 2.25 | 25.82 ± 4.97a | 26.31 ± 4.82a | 149.762 | <0.001 |
| AST (U/l) | 15.31 ± 2.27 | 27.78 ± 5.5a | 27.82 ± 3.91a | 150.723 | <0.001 |
| Creatinine (mg/dl) | 52.35 ± 5.06 | 70.2 ± 13.39a | 87.12 ± 7.05ab | 174.695 | <0.001 |
Results are expressed as mean ± SD. LDH: lactate dehydrogenase; ALT: alanine aminotransferase; AST: aspartate aminotransferase. aSignificantly different from the control group. bSignificantly different from the type 1 diabetic patients. p < 0.05 is considered significant.